study Correlation n=366 0 0 -1 0 No Correlation (range): See results for AMH Not important ⨁⨀⨀⨀ between AMH testing’ column (unknown k=5 Low risk All positive No evidence Positive: 0.62 (0.44–0.83), k=4 Very low and AFC how to use of bias moderate to of incremental quality Case series Pre-cancer: 0.48 (0.44–0.52), this evidence strong value of AMH k=2 in clinical correlations was provided Post-cancer: 0.72, k=1 practice) Post-childhood cancer: 0.83, k=1 Pre-endo surgery: 0.842 (k=1) Correlation n=462 0 -1 -1 -1 No Negative: -0.50 (-0.52, -0.47; See results for AMH Not important ⨁⨀⨀⨀ between AMH k=2), NS (k=3) testing’ column (unknown Low risk Inconsistent No evidence k=7 Very low how to use and FSH of bias results between of incremental Pre-cancer: -0.47, k=1, NS, k=2 quality Case series this evidence studies value of AMH and Post-cancer: NS, k=1 in clinical was provided Post-childhood cancer: -0.52, practice) k=1 results Serum AMH versus serum FSH levels: NS, k=3 Detectable AMH versus serum FHS: -0.55, k=1 Correlation n=331 0 -1 -1 -1 No Positive: 0.30 (0.15–0.44), k=2 See results for AMH Not important ⨁⨀⨀⨀ between AMH testing’ column (unknown k=4 Low risk Inconsistent No evidence Negative: -0.64, k=1 Very low and E2 how to use of bias results between of incremental quality Case series Pre-cancer -0.64 and 0.15, k=2 this evidence studies value of AMH and Positive post-cancer: 0.44, k=1 in clinical was provided Pre- and post-cancer: NS (k=1) practice) results
study Correlation between AMH and AFC n=366 k=5 Case series 0 Low risk of bias 0 All positive moderate to strong correlations -1 No evidence of incremental value of AMH was provided 0 No Correlation (range): Positive: 0.62 (0.44–0.83), k=4 Pre-cancer: 0.48 (0.44–0.52), k=2 Post-cancer: 0.72, k=1 Post-childhood cancer: 0.83, k=1 Pre-endo surgery: 0.842 (k=1) See results for AMH testing’ column ⨁⨀⨀⨀ Very low quality Not important (unknown how to use this evidence in clinical practice) Correlation between AMH and FSH n=462 k=7 Case series 0 Low risk of bias -1 Inconsistent results between studies -1 No evidence of incremental value of AMH was provided -1 and results No Negative: -0.50 (-0.52, -0.47; k=2), NS (k=3) Pre-cancer: -0.47, k=1, NS, k=2 Post-cancer: NS, k=1 Post-childhood cancer: -0.52, k=1 Serum AMH versus serum FSH levels: NS, k=3 Detectable AMH versus serum FHS: -0.55, k=1 See results for AMH testing’ column ⨁⨀⨀⨀ Very low quality Not important (unknown how to use this evidence in clinical practice) Correlation between AMH and E2 n=331 k=4 Case series 0 Low risk of bias -1 Inconsistent results between studies -1 No evidence of incremental value of AMH was provided -1 and results No Positive: 0.30 (0.15–0.44), k=2 Negative: -0.64, k=1 Pre-cancer -0.64 and 0.15, k=2 Positive post-cancer: 0.44, k=1 Pre- and post-cancer: NS (k=1) See results for AMH testing’ column ⨁⨀⨀⨀ Very low quality Not important (unknown how to use this evidence in clinical practice)
1434-Assessment_Report-Accessible.docx